BGI’s share value exceeds 100 billion Yuan

As a leading enterprise in China’s genetic testing industry, BGI combines strong R & D self-developed instruments and reagents to effectively control costs. The rapid growth of the reproductive and health businesses has formed a scale effect and BGI is active in...

China’s main cause of liver cancer is viral hepatitis

According to a national liver cancer clinical registration survey, 83 % of patients were male, and infection (58 %) and/or alcohol consumption was the main cause of disease. China Bio news release, November 14, 2017

5 Chinese companies among the global top 25 in market capitalization

According to a survey by Genetic Engineering News (GEN), the following 5 companies have entered the top 15 ranks: Sinopharm Holdings (24), Jiangsu Hengrui Pharmaceutical (13), Yunnan Baiyao Group (18), Kangmei Pharmaceutical (19) and Shanghai Fosun Pharmaceutical...

China rüstet Beidou-Satellitensystem für globale Reichweite auf

Zwei Beidou-Satelliten der dritten Generation, die ersten ihrer Art, wurden am 5. November von einer Long March 3B Trägerrakete vom Xichang Satellite Launch Center in der Provinz Sichuan gestartet und in eine mittlere Erdumlaufbahn gebracht. Die neuen...